news
Aptar Pharma extends nasal pump manufacturing capabilities
Aptar Pharma has announced the installation of manufacturing capacity for its child-resistant and Senior-Friendly Classic Nasal Pump in their Congers, NY site.
List view / Grid view
Drug delivery
article
Analytical techniques for faster development of drug delivery systems
The challenge of efficiently delivering a drug to its site of action, while maintaining its efficacy and minimising its potential toxicity, has received much attention in recent years, with the growing use of complex and often delicate biological molecules as therapeutic agents...
article
Shashank Jain on formulation for drug delivery via the skin
EPR Editor Steve Bremer discusses drug delivery through the skin with Shashank Jain, Formulation Research Scientist at G&W Laboratories.
news
FDA approves first cancer treatment for any solid tumor with a specific biomarker
24 May 2017 | By Niamh Marriott, Junior Editor
The US Food and Drug Administration granted accelerated approval to a treatment for patients whose cancers have a specific genetic feature (biomarker)...
news
Antibiotic therapy for nearly 1 in 4 adults with pneumonia does not work
22 May 2017 | By Niamh Marriott, Junior Editor
Approximately one in four adults prescribed an antibiotic in an outpatient setting for community-acquired pneumonia does not respond to treatment...
news
SpeeDx and Thermo Fisher Scientific announce strategic partnership for FDA clearance of molecular diagnostic test
ResistancePlus™ MG Test would bring disease and antibiotic resistance testing for potential “superbug”...
news
Roche receives FDA approval for bladder cancer biomarker assay
5 May 2017 | By Niamh Marriott, Junior Editor
The FDA has approved Roche’s biomarker assay as a complementary diagnostic to provide PD-L1 status for patients with urothelial carcinoma...
news
FDA approves new combination treatment for acute myeloid leukaemia
4 May 2017 | By Niamh Marriott, Junior Editor
The drug is approved for use in combination with LeukoStrat CDx FLT3 Mutation Assay, which is used to detect the FLT3 mutation in patients with AML...
news
Novartis real-world data confirms benefit of Gilenya in relapsing MS
28 April 2017 | By Niamh Marriott, Junior Editor
Novartis announced data from the MS-MRIUS study, which confirmed the effectiveness of Gilenya (fingolimod) in the real-world setting...
news
Protein targeting antibiotics bring new hope against multi-drug resistance
27 April 2017 | By Niamh Marriott, Junior Editor
Polyphor presented promising data for their novel class of antibiotics, the Outer Membrane Protein Targeting Antibiotics (OMPTA)...
news
BMS Phase II study in non-alcoholic steatohepatitis a success
24 April 2017 | By Niamh Marriott, Junior Editor
BMS-986036 is a pegylated analogue of human fibroblast growth factor 21, a key regulator of metabolism. In preclinical models of non-alcoholic steatohepatitis (NASH), BMS-986036 improved steatosis, inflammation, hepatocyte ballooning, and fibrosis.
news
Rainin TerraRack™ benefits cell differentiation studies
21 April 2017 | By METTLER TOLEDO
METTLER TOLEDO’s Rainin TerraRack™ pipette tip racks are proving advantageous for the University of Glasgow’s Centre for Cell Engineering, where scientists are investigating cell differentiation and behavior on a variety of materials...
news
GeNeuro initiates Phase 2a study in Australia to treat Type 1 Diabetes
19 April 2017 | By Niamh Marriott, Junior Editor
GeNeuro have started a Phase 2a clinical study in Australia with GNbAC1 in patients with Type 1 diabetes. GNbAC1 is a monoclonal antibody designed to...
article
Issue #2 2017 – Digital version
Read the free-to-view digital version of the latest issue of European Pharmaceutical Review...
article
How Panacea is paving the way for vaccine immunotherapies
29 March 2017 | By Niamh Marriott, Junior Editor
We caught up with the CEO & CSO of Panacea for the latest on vaccine immunotherapies - "As a scientist, as long as you are observant and persistent, you may come up with breakthrough discoveries"
